Phosphorylation of myofibrillogenesis regulator-1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cells (Q24301472)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Phosphorylation of myofibrillogenesis regulator-1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cells	scientific article

Statements

scholarly article

0 references

Phosphorylation of myofibrillogenesis regulator-1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cells (English)

0 references

phosphorylation

1 reference

based on heuristic

inferred from title

author name string

Yuyan Gong

1

0 references

Hongwei He

2

0 references

Hong Liu

3

0 references

Caixia Zhang

4

0 references

Wuli Zhao

5

0 references

Rong-Guang Shao

6

0 references

language of work or name

0 references

publication date

25 August 2014

0 references

0 references

588

0 references

17

0 references

2903-10

0 references

Comprehensive molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

The role of mitogen-activated protein (MAP) kinase in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

EGF-receptor-mediated mammary epithelial cell migration is driven by sustained ERK signaling from autocrine stimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Estrogen receptor signaling as a target for novel breast cancer therapeutics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

MR-1 modulates proliferation and migration of human hepatoma HepG2 cells through myosin light chains-2 (MLC2)/focal adhesion kinase (FAK)/Akt signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

MR-1 blocks the megakaryocytic differentiation and transition of CML from chronic phase to blast crisis through MEK dephosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Bacillus Calmette-Guérin and TLR4 agonist prevent cardiovascular hypertrophy and fibrosis by regulating immune microenvironment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Survivin expression quantified by Image Pro-Plus compared with visual assessment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Coordinated control of renal Ca(2+) transport proteins by parathyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

FOXM1 confers acquired cisplatin resistance in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

An efficient one-step site-directed and site-saturation mutagenesis protocol

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Clinicopathological and prognostic significance of myofibrillogenesis regulator-1 protein expression in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

21 January 2018

COX2 expression and Erk1/Erk2 activity mediate Cot-induced cell migration

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of ERK activity in the regulation of cyclin D1 levels and DNA synthesis in human cultured airway smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

7 January 2021

based on heuristic

inferred from DOI database lookup

The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

7 January 2021

based on heuristic

inferred from DOI database lookup

The invasive phenotype in HMT-3522 cells requires increased EGF receptor signaling through both PI 3-kinase and ERK 1,2 pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.07.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.FEBSLET.2014.07.018

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24301472&oldid=1475355079"